OTTAWA, March 7, 2016 /CNW/ -
The issue:
Vivo Brand Management Inc. is recalling more natural health products promoted for sexual enhancement: Forta for Men Daily, Forta Xpload and Durazest For Men Volume. As in previous recalls, these products may contain an undeclared drug: sildenafil. Sildenafil is a prescription drug that should only be used under the supervision of a health-care practitioner and may pose serious health risks.
Health Canada is in the process of suspending all affected product licences given the inclusion of prescription drug ingredients.
Products affected:
Forta for Men Daily (NPN 80054633), available in bottles of 30 capsules.
Forta Xpload; Durazest For Men Volume; X-Delite Volumizer (NPN 80035218), available in bottles of 60 capsules and blister packs of 2 capsules.
Who is affected:
Consumers who have bought or used Forta for Men Daily, Forta Xpload and Durazest For Men Volume, particularly those with heart conditions.
What consumers should do
What Health Canada is doing:
Health Canada is monitoring this recall and following up with the licence holder to determine the source of the undeclared drug.
Background:
Products containing sildenafil can only be sold pursuant to a prescription. Products containing sildenafil or its analogs (very similar substances) should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure.
Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardiovascular side-effects if they use sildenafil and engage in sexual activity. Other possible side-effects of using sildenafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
How to report side effects to health products to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada
PDF available at: http://stream1.newswire.ca/media/2016/03/07/20160307_C5985_PDF_EN_637118.pdf
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Share this article